{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:20:13Z","timestamp":1793035213053,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,19]],"date-time":"2020-01-19T00:00:00Z","timestamp":1579392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,19]],"date-time":"2020-01-19T00:00:00Z","timestamp":1579392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13187-020-01689-2","type":"journal-article","created":{"date-parts":[[2020,1,19]],"date-time":"2020-01-19T00:02:47Z","timestamp":1579392167000},"page":"1022-1029","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Adherence to Antiemetic Treatment Guidelines in Patients With Chemotherapy-Induced Nausea and Vomiting in Teaching Hospitals in Tehran"],"prefix":"10.1007","volume":"36","author":[{"given":"Zahra","family":"Nikbakht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolali","family":"Shahrasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Roohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Hashemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,19]]},"reference":[{"key":"1689_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/2278-330X.149923","volume":"4","author":"S Hingmire","year":"2015","unstructured":"Hingmire S, Raut N (2015) Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy\/moderately emetogenic chemotherapy regimens. South Asian J Cancer 4:7\u201310. https:\/\/doi.org\/10.4103\/2278-330X.149923","journal-title":"South Asian J Cancer"},{"key":"1689_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11096-010-9454-1","volume":"33","author":"D Perwitasari","year":"2011","unstructured":"Perwitasari D, Gelderblom H, Atthobari J, Mustofa M, Dwiprahasto I, Nortier JW, Guchelaar HJ (2011) Anti- emetic drugs in oncology: pharmacology and individualization by pharmacogenetics. Int J Clin Pharm 33:33\u201343. https:\/\/doi.org\/10.1007\/s11096-010-9454-1","journal-title":"Int J Clin Pharm"},{"key":"1689_CR3","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJMra1515442","volume":"374","author":"RM Navari","year":"2016","unstructured":"Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374:1356\u20131367. https:\/\/doi.org\/10.1056\/NEJMra1515442","journal-title":"N Engl J Med"},{"key":"1689_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1078155214546563","volume":"22","author":"D Daniel","year":"2016","unstructured":"Daniel D, Waddell A (2016) Compliance with national comprehensive cancer network anti-emesis guidelines in a community hospital cancer center. J Oncol Pharm Pract 22:26\u201330. https:\/\/doi.org\/10.1177\/1078155214546563","journal-title":"J Oncol Pharm Pract"},{"key":"1689_CR5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1634\/theoncologist.12-9-1143","volume":"12","author":"K Jordan","year":"2007","unstructured":"Jordan K, Sippel C, Schmoll H-J (2007) Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Oncologist 12:1143\u20131150","journal-title":"Oncologist"},{"key":"1689_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/BCTT.S12955","volume":"3","author":"VT Chan","year":"2011","unstructured":"Chan VT, Yeo W (2011) Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients. Breast Cancer (Dove Med press) 3:151\u2013160. https:\/\/doi.org\/10.2147\/BCTT.S12955","journal-title":"Breast Cancer (Dove Med press)"},{"key":"1689_CR7","doi-asserted-by":"publisher","unstructured":"Pirri C, Katris P, Trotter J, Bayliss E, Bennett R, Drummond P (2011) Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study. Support Care Cancer 19:1549\u20131563. https:\/\/doi.org\/10.1007\/s00520-010-0982-y Epub 2010 Sep 3","DOI":"10.1007\/s00520-010-0982-y"},{"key":"1689_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00520-010-1073-9","volume":"20","author":"DL Hilarius","year":"2012","unstructured":"Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJG, Gundy CM, Aaronson NK (2012) Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer 20:107\u2013117. https:\/\/doi.org\/10.1007\/s00520-010-1073-9","journal-title":"Support Care Cancer"},{"key":"1689_CR9","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1007\/s00520-013-1843-2","volume":"21","author":"A Molassiotis","year":"2013","unstructured":"Molassiotis A, Stamataki Z, Kontopantelis E (2013) Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer 21:2759\u20132767. https:\/\/doi.org\/10.1007\/s00520-013-1843-2","journal-title":"Support Care Cancer"},{"key":"1689_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jpainsymman.2013.06.012","volume":"47","author":"A Molassiotis","year":"2014","unstructured":"Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N et al (2014) Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J pain symptom manage 47:839\u201348.e4. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.06.012","journal-title":"J pain symptom manage"},{"key":"1689_CR11","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/s00520-017-3679-7","volume":"25","author":"T Hayashi","year":"2017","unstructured":"Hayashi T, Shimokawa M, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M (2017) A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy- induced nausea and vomiting. Support Care Cancer 25:2707\u20132714. https:\/\/doi.org\/10.1007\/s00520-017-3679-7","journal-title":"Support Care Cancer"},{"key":"1689_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fphar.2017.00019","volume":"8","author":"BL Rapoport","year":"2017","unstructured":"Rapoport BL (2017) Delayed chemotherapy-induced nausea and vomiting: pathogenesis, incidence, and current management. Front Pharmacol 8:19. https:\/\/doi.org\/10.3389\/fphar.2017.00019","journal-title":"Front Pharmacol"},{"key":"1689_CR13","unstructured":"Aapro M, Gralla RJ, Herrstedt J, Molassiotis A, Roila F.2016 MASCC\/ESMO antiemetic guideline"},{"key":"1689_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1200\/JCO.2015.64.3635","volume":"34","author":"PJ Hesketh","year":"2016","unstructured":"Hesketh PJ, Bohlke K, Lyman GH, Basch E, Chesney M, Clark-Snow RA, Danso MA, Jordan K, Somerfield MR, Kris MG, American Society of Clinical Oncology (2016) Antiemetics: American Society of Clinical Oncology focused guideline update. J Clin Oncol 34:381\u2013386. https:\/\/doi.org\/10.1200\/JCO.2015.64.3635","journal-title":"J Clin Oncol"},{"key":"1689_CR15","unstructured":"National Comprehensive Cancer Network (NCCN) 2017Antiemesis. NCCN Guidelines; Version 2 https:\/\/www.nccn.org\/professionals\/physician_gls\/ accessed 22 February 2017"},{"key":"1689_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/1043454214563403","volume":"32","author":"M Wood","year":"2015","unstructured":"Wood M, Hall L, Hockenberry M, Borinstein S (2015) Improving adherence to evidence-based guidelines for chemotherapy-induced nausea and vomiting. J Pediatr Oncol Nurs 32:195\u2013200. https:\/\/doi.org\/10.1177\/1043454214563403","journal-title":"J Pediatr Oncol Nurs"},{"key":"1689_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jsps.2015.01.003","volume":"23","author":"M Zaidan","year":"2015","unstructured":"Zaidan M, Soufi L, Hafeez M, Abdelwahid M, Rasul K (2015) Assessing prescribing patterns for the prevention of CT-induced nausea and vomiting in the national center for cancer care and research. Saudi Pharm J 23:381\u2013387. https:\/\/doi.org\/10.1016\/j.jsps.2015.01.003","journal-title":"Saudi Pharm J"},{"key":"1689_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JOP.2012.000816","volume":"10","author":"JW Gilmore","year":"2014","unstructured":"Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharpe J et al (2014) Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US Community oncology practice: INSPIRE study. J Oncol Pract 10:68\u201374. https:\/\/doi.org\/10.1200\/JOP.2012.000816","journal-title":"J Oncol Pract"},{"key":"1689_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1470-2045(05)70284-9","volume":"6","author":"R Kaiser","year":"2005","unstructured":"Kaiser R (2005) Antiemetic guidelines: are they being used? Lancet Oncol 6:622\u2013625","journal-title":"Lancet Oncol"},{"key":"1689_CR20","doi-asserted-by":"publisher","unstructured":"Bo\u0161njak SM, Gralla RJ, Schwartzberg L (2017) Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists. Support care Cancer:1\u201311. https:\/\/doi.org\/10.1007\/s00520-017-3585-z","DOI":"10.1007\/s00520-017-3585-z"},{"key":"1689_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s005200100273","volume":"9","author":"G Dranitsaris","year":"2001","unstructured":"Dranitsaris G, Leung P, Warr D (2001) Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. Support Care Cancer 9:611\u2013618. https:\/\/doi.org\/10.1007\/s005200100273","journal-title":"Support Care Cancer"},{"key":"1689_CR22","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/annonc\/mds021","volume":"23","author":"M Aapro","year":"2012","unstructured":"Aapro M, Molassiotis A, Dicato M, Pel\u00e1ez I, Rodr\u00edguez-Lescure \u00c1, Pastorelli D, Ma L, Burke T, Gu A, Gascon P, Roila F, PEER investigators (2012) The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis registry (PEER). Ann Oncol 23:1986\u20131992","journal-title":"Ann Oncol"},{"key":"1689_CR23","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s00520-013-1835-2","volume":"21","author":"S Miura","year":"2013","unstructured":"Miura S, Watanabe S, Sato K, Makino M, Kobayashi O, Miyao H, Iwashima A, Okajima M, Tanaka J, Tanaka H, Kagamu H, Yokoyama A, Narita I, Yoshizawa H (2013) The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy. Support Care Cancer 21:2575\u20132581","journal-title":"Support Care Cancer"},{"key":"1689_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejphar.2013.09.073","volume":"722","author":"K Jordan","year":"2014","unstructured":"Jordan K, Gralla R, Jahn F, Molassiotis A (2014) International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice. Eur J Pharmacol 722:197\u2013202. https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.073","journal-title":"Eur J Pharmacol"},{"key":"1689_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1078155214524809","volume":"21","author":"F Caracuel","year":"2015","unstructured":"Caracuel F, Mu\u00f1oz N, Ba\u00f1os U, Ramirez G (2015) Adherence to antiemetic guidelines and control of chemotherapy-induced nausea and vomiting (CINV) in a large hospital. J Oncol Pharm Pract 21:163\u2013169. https:\/\/doi.org\/10.1177\/1078155214524809","journal-title":"J Oncol Pharm Pract"},{"key":"1689_CR26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00520-010-0909-7","volume":"19","author":"A Molassiotis","year":"2011","unstructured":"Molassiotis A, Brearley SG, Stamataki Z (2011) Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice. Support Care Cancer 19:949\u2013956. https:\/\/doi.org\/10.1007\/s00520-010-0909-7","journal-title":"Support Care Cancer"},{"key":"1689_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jamaoncol.2016.4096","volume":"3","author":"A Okuyama","year":"2017","unstructured":"Okuyama A, Nakamura F, Higashi T (2017) Prescription of prophylactic antiemetic drugs for patients receiving chemotherapy with minimal and low emetic risk. JAMA Oncol 3:344\u2013350. https:\/\/doi.org\/10.1001\/jamaoncol.2016.4096","journal-title":"JAMA Oncol"},{"key":"1689_CR28","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00520-017-3658-z","volume":"25","author":"K Thavorn","year":"2017","unstructured":"Thavorn K, Coyle D, Hoch JS, Vandermeer L, Mazzarello S, Wang Z, Dranitsaris G, Fergusson D, Clemons M (2017) A cost-utility analysis of risk model-guided versus physician\u2019s choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach. Support Care Cancer 25:2505\u20132513. https:\/\/doi.org\/10.1007\/s00520-017-3658-z","journal-title":"Support Care Cancer"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-020-01689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13187-020-01689-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-020-01689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T03:02:15Z","timestamp":1634526135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13187-020-01689-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,19]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1007\/s13187-020-01689-2","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"value":"0885-8195","type":"print"},{"value":"1543-0154","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,19]]},"assertion":[{"value":"19 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol was approved by the local ethics committee. All procedures performed in the study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}